Department of Internal and Integrative Medicine, Faculty of Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Essen, Germany.
Aliment Pharmacol Ther. 2018 Jan;47(2):203-211. doi: 10.1111/apt.14400. Epub 2017 Oct 27.
Irritable bowel syndrome is the most frequent gastrointestinal disorder. It is assumed that lifestyle interventions might be a rational treatment approach.
To examine the effect of a yoga-based intervention vs a low-FODMAP diet on patients with irritable bowel syndrome.
Fifty-nine patients with irritable bowel syndrome undertook a single-blind, randomised controlled trial involving yoga or a low-FODMAP diet for 12 weeks. Patients in the yoga group received two sessions weekly, while patients in the low-FODMAP group received a total of three sessions of nutritional counselling. The primary outcome was a change in gastrointestinal symptoms (IBS-SSS). Secondary outcomes explored changes in quality of life (IBS-QOL), health (SF-36), perceived stress (CPSS, PSQ), body awareness (BAQ), body responsiveness (BRS) and safety of the interventions. Outcomes were examined in weeks 12 and 24 by assessors "blinded" to patients' group allocation.
No statistically significant difference was found between the intervention groups, with regard to IBS-SSS score, at either 12 (Δ = 31.80; 95%CI = -11.90, 75.50; P = .151) or 24 weeks (Δ = 33.41; 95%CI = -4.21, 71.04; P = .081). Within-group comparisons showed statistically significant effects for yoga and low-FODMAP diet at both 12 and 24 weeks (all P < .001). Comparable within-group effects occurred for the other outcomes. One patient in each intervention group experienced serious adverse events (P = 1.00) and another, also in each group, experienced nonserious adverse events (P = 1.00).
Patients with irritable bowel syndrome might benefit from yoga and a low-FODMAP diet, as both groups showed a reduction in gastrointestinal symptoms. More research on the underlying mechanisms of both interventions is warranted, as well as exploration of potential benefits from their combined use.
肠易激综合征是最常见的胃肠道疾病。人们认为生活方式干预可能是一种合理的治疗方法。
研究基于瑜伽的干预与低 FODMAP 饮食对肠易激综合征患者的影响。
59 例肠易激综合征患者进行了一项单盲、随机对照试验,接受瑜伽或低 FODMAP 饮食治疗 12 周。瑜伽组每周接受两次治疗,低 FODMAP 组共接受三次营养咨询。主要结局是胃肠道症状(IBS-SSS)的变化。次要结局包括生活质量(IBS-QOL)、健康状况(SF-36)、感知压力(CPSS、PSQ)、身体意识(BAQ)、身体反应性(BRS)以及干预安全性的变化。在 12 周和 24 周时,评估人员对患者分组情况进行“盲法”评估,以评估结局。
在 12 周和 24 周时,两组之间的 IBS-SSS 评分均无统计学差异,分别为 31.80(95%CI=-11.90,75.50;P=.151)和 33.41(95%CI=-4.21,71.04;P=.081)。组内比较显示,瑜伽和低 FODMAP 饮食在 12 周和 24 周时均有统计学显著效果(均 P <.001)。其他结局也出现了类似的组内效应。每组各有 1 例患者发生严重不良事件(P=1.00),每组各有 1 例患者发生非严重不良事件(P=1.00)。
肠易激综合征患者可能受益于瑜伽和低 FODMAP 饮食,因为两组患者的胃肠道症状均有所减轻。需要进一步研究这两种干预措施的潜在机制,并探讨它们联合应用的潜在益处。